Skip to main content
Top
Published in: AIDS and Behavior 2/2018

01-02-2018 | Original Paper

Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex

Authors: Nicole D. Laborde, Elizabeth Pleasants, Krishnaveni Reddy, Millicent Atujuna, Teopista Nakyanzi, Miria Chitukuta, Sarita Naidoo, Thesla Palanee-Phillips, Jared M. Baeten, Elizabeth T. Montgomery, On behalf of the MTN-020/ASPIRE Study Team

Published in: AIDS and Behavior | Issue 2/2018

Login to get access

Abstract

Vaginally-inserted HIV prevention methods have been reported to impact the sexual experience for women and their partners, and hence impacts acceptability of and adherence to the method. We analyzed in-depth interviews and focus group discussions about participants’ sexual experiences while wearing the ring, collected during the MTN-020/ASPIRE phase 3 safety and effectiveness trial of a dapivirine vaginal ring for HIV prevention in Malawi, South Africa, Uganda, and Zimbabwe. Most women reported that partners did not feel the ring during sex, however, women felt they had to manage their partners’ interaction with or reaction to the ring. In maintaining positive relationships, women were concerned about partners’ discovering ring use and about ensuring that partners had a good sexual experience with them. Finally women were concerned about how they themselves experienced sex with the ring. Some found that the ring made the vaginal environment more desirable for their partners and themselves.
Literature
1.
go back to reference Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375:2121–32.CrossRefPubMedPubMedCentral Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375:2121–32.CrossRefPubMedPubMedCentral
2.
go back to reference Montgomery ET, van der Straten A, Chitukuta M, et al. “It’s inside my body and it’s mine”: Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31:1159–67.CrossRefPubMedPubMedCentral Montgomery ET, van der Straten A, Chitukuta M, et al. “It’s inside my body and it’s mine”: Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31:1159–67.CrossRefPubMedPubMedCentral
3.
go back to reference Nel A, Bekker LG, Bukusi E, et al. Safety, acceptability and adherence of dapivirine vaginal ring in a microbicide clinical trial conducted in multiple countries in Sub-Saharan Africa. PLoS ONE. 2016;11(3):e0147743.CrossRefPubMedPubMedCentral Nel A, Bekker LG, Bukusi E, et al. Safety, acceptability and adherence of dapivirine vaginal ring in a microbicide clinical trial conducted in multiple countries in Sub-Saharan Africa. PLoS ONE. 2016;11(3):e0147743.CrossRefPubMedPubMedCentral
4.
go back to reference Kiser P, Johnson T, Clark J. State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. AIDS Rev. 2012;14(1):62–77.PubMed Kiser P, Johnson T, Clark J. State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. AIDS Rev. 2012;14(1):62–77.PubMed
5.
go back to reference Malcolm RK, Edwards K-L, Kiser P, Romano J, Smith TJ. Advances in microbicide vaginal rings. Antiviral Res. 2010;88:S30–9.CrossRefPubMed Malcolm RK, Edwards K-L, Kiser P, Romano J, Smith TJ. Advances in microbicide vaginal rings. Antiviral Res. 2010;88:S30–9.CrossRefPubMed
6.
go back to reference Woodsong C, Holt JD. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy. Adv Drug Deliv Rev. 2015;92:146–54.CrossRefPubMed Woodsong C, Holt JD. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy. Adv Drug Deliv Rev. 2015;92:146–54.CrossRefPubMed
7.
go back to reference Montgomery CM, Gafos M, Lees S, et al. Re-framing microbicide acceptability: findings from the MDP301 trial. Cult Health Sex. 2010;12(6):649–62.CrossRefPubMed Montgomery CM, Gafos M, Lees S, et al. Re-framing microbicide acceptability: findings from the MDP301 trial. Cult Health Sex. 2010;12(6):649–62.CrossRefPubMed
8.
go back to reference Gafos M, Mzimela M, Sukazi S, Pool R, Montgomery C, Elford J. Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use. Cult Health Sex. 2010;12(8):929–42.CrossRefPubMedPubMedCentral Gafos M, Mzimela M, Sukazi S, Pool R, Montgomery C, Elford J. Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use. Cult Health Sex. 2010;12(8):929–42.CrossRefPubMedPubMedCentral
9.
go back to reference Mensch BS, van der Straten A, Katzen LL. Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS. 2012;7(6):534–41.CrossRefPubMedPubMedCentral Mensch BS, van der Straten A, Katzen LL. Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS. 2012;7(6):534–41.CrossRefPubMedPubMedCentral
10.
go back to reference Woodsong C, Montgomery E, Masenga G, et al. Safety and Acceptability of Vaginal Ring as Microbicide Delivery Method in African Women. Paper presented at: Microbicides 2010; May 23–26, 2010; Pittsburg, PA. Woodsong C, Montgomery E, Masenga G, et al. Safety and Acceptability of Vaginal Ring as Microbicide Delivery Method in African Women. Paper presented at: Microbicides 2010; May 23–26, 2010; Pittsburg, PA.
11.
go back to reference Severy LJ, Newcomer S. Critical issues in contraceptive and STI acceptability research. Journal of Social Issues. 2005;61(1):45–65.CrossRef Severy LJ, Newcomer S. Critical issues in contraceptive and STI acceptability research. Journal of Social Issues. 2005;61(1):45–65.CrossRef
12.
go back to reference Hilber AM, Chersich MF, van de Wijgert JHHM, Rees H, Temmerman M. Vaginal practices, microbicides and HIV: what do we need to know? Sex Trans Inf. 2007;83(7):505–8.CrossRef Hilber AM, Chersich MF, van de Wijgert JHHM, Rees H, Temmerman M. Vaginal practices, microbicides and HIV: what do we need to know? Sex Trans Inf. 2007;83(7):505–8.CrossRef
13.
go back to reference Jewkes R, Morrell R. Gender and sexuality: emerging perspectives from the heterosexual epidemic in South Africa and implications for HIV risk and prevention. J Int AIDS Soc. 2010;13(1):1–11.CrossRef Jewkes R, Morrell R. Gender and sexuality: emerging perspectives from the heterosexual epidemic in South Africa and implications for HIV risk and prevention. J Int AIDS Soc. 2010;13(1):1–11.CrossRef
14.
go back to reference Gafos M, Pool R, Mzimela MA, Ndlovu HB, McCormack S, Elford J. Communication about microbicide use between couples in KwaZulu-Natal, South Africa. AIDS Behav. 2015;19(5):832–46.CrossRefPubMed Gafos M, Pool R, Mzimela MA, Ndlovu HB, McCormack S, Elford J. Communication about microbicide use between couples in KwaZulu-Natal, South Africa. AIDS Behav. 2015;19(5):832–46.CrossRefPubMed
15.
go back to reference GUaJ. Estimates. Geneva: UNAIDS; 2016. p. 2016. GUaJ. Estimates. Geneva: UNAIDS; 2016. p. 2016.
16.
go back to reference Jewkes R, Morrell R. Sexuality and the limits of agency among South African teenage women: theorising femininities and their connections to HIV risk practices. Soc Sci Med. 2012;74(11):1729–37.CrossRefPubMed Jewkes R, Morrell R. Sexuality and the limits of agency among South African teenage women: theorising femininities and their connections to HIV risk practices. Soc Sci Med. 2012;74(11):1729–37.CrossRefPubMed
17.
go back to reference Morrell R, Jewkes R, Lindegger G. Hegemonic masculinity/masculinities in South Africa: culture, power, and gender politics. Men Masc. 2012;15:11–30.CrossRef Morrell R, Jewkes R, Lindegger G. Hegemonic masculinity/masculinities in South Africa: culture, power, and gender politics. Men Masc. 2012;15:11–30.CrossRef
18.
go back to reference Pettifor A, MacPhail C, Anderson AD, Maman S. ‘If I buy the Kellogg’s then he should [buy] the milk’: young women’s perspectives on relationship dynamics, gender power and HIV risk in Johannesburg, South Africa. Cult Health Sex. 2012;14(5):477–90.CrossRefPubMedPubMedCentral Pettifor A, MacPhail C, Anderson AD, Maman S. ‘If I buy the Kellogg’s then he should [buy] the milk’: young women’s perspectives on relationship dynamics, gender power and HIV risk in Johannesburg, South Africa. Cult Health Sex. 2012;14(5):477–90.CrossRefPubMedPubMedCentral
19.
go back to reference Montgomery CM. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733–40.CrossRefPubMed Montgomery CM. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733–40.CrossRefPubMed
20.
go back to reference Montgomery ET, Stadler J, Hartmann M, et al. Male partner roles and influence on women’s use of HIV pre-exposure prophylaxis in Johannesburg. Paper presented at: AIDS Impact; Sept 29–Oct 3, 2013, 2013; Barcelona, Spain. Montgomery ET, Stadler J, Hartmann M, et al. Male partner roles and influence on women’s use of HIV pre-exposure prophylaxis in Johannesburg. Paper presented at: AIDS Impact; Sept 29–Oct 3, 2013, 2013; Barcelona, Spain.
21.
go back to reference Green G, Pool R, Harrison S, et al. Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda. Soc Sci Med. 2001;52(4):585–98.CrossRefPubMed Green G, Pool R, Harrison S, et al. Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda. Soc Sci Med. 2001;52(4):585–98.CrossRefPubMed
22.
go back to reference Woodsong C. Covert use of topical microbicides: implications for acceptability and use. Int Fam Plan Perspect. 2004;30(2):94–8.CrossRefPubMed Woodsong C. Covert use of topical microbicides: implications for acceptability and use. Int Fam Plan Perspect. 2004;30(2):94–8.CrossRefPubMed
23.
go back to reference Hilber AM, Kenter E, Redmond S, et al. Vaginal practices as women’s agency in Sub-Saharan Africa: A synthesis of meaning and motivation through meta-ethnography. Soc Sci Med. 2012;74(9):1311–23.CrossRef Hilber AM, Kenter E, Redmond S, et al. Vaginal practices as women’s agency in Sub-Saharan Africa: A synthesis of meaning and motivation through meta-ethnography. Soc Sci Med. 2012;74(9):1311–23.CrossRef
24.
go back to reference Scorgie F, Smit JA, Kunene B, Martin-Hilber A, Beksinska M, Chersich MF. Predictors of vaginal practices for sex and hygiene in KwaZulu-Natal, South Africa: findings of a household survey and qualitative inquiry. Cult Health Sex. 2011;13(04):381–98.CrossRefPubMed Scorgie F, Smit JA, Kunene B, Martin-Hilber A, Beksinska M, Chersich MF. Predictors of vaginal practices for sex and hygiene in KwaZulu-Natal, South Africa: findings of a household survey and qualitative inquiry. Cult Health Sex. 2011;13(04):381–98.CrossRefPubMed
25.
go back to reference Duby Z, Mensch B, Hartmann M, et al. Achieving the optimal vaginal state: the use of vaginal products and study gels in Uganda, Zimbabwe and South Africa. Int Persp Sex Reprod Health. 2017;29:247–57.CrossRef Duby Z, Mensch B, Hartmann M, et al. Achieving the optimal vaginal state: the use of vaginal products and study gels in Uganda, Zimbabwe and South Africa. Int Persp Sex Reprod Health. 2017;29:247–57.CrossRef
26.
27.
go back to reference Lete I, Cuesta MC, Marín JM, Guerra S. Vaginal health in contraceptive vaginal ring users—A review. Eur J Contracept Reprod Health Care. 2013;18(4):234–41.CrossRefPubMed Lete I, Cuesta MC, Marín JM, Guerra S. Vaginal health in contraceptive vaginal ring users—A review. Eur J Contracept Reprod Health Care. 2013;18(4):234–41.CrossRefPubMed
28.
go back to reference Brown E, Palanee-Philips Marzinke, Hendrix C, Dezutti C. Residual dapivirine ring levels indicate higher adherence to vaginal ring is associated with HIV-1 protection. Durban: International AIDS Society; 2016. Brown E, Palanee-Philips Marzinke, Hendrix C, Dezutti C. Residual dapivirine ring levels indicate higher adherence to vaginal ring is associated with HIV-1 protection. Durban: International AIDS Society; 2016.
29.
go back to reference Montgomery ET, van der Straten A, Stadler J, et al. Male partner influence on women’s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of “Understanding”. AIDS Behav. 2014;19(5):784–93.CrossRef Montgomery ET, van der Straten A, Stadler J, et al. Male partner influence on women’s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of “Understanding”. AIDS Behav. 2014;19(5):784–93.CrossRef
30.
go back to reference Montgomery ET, van der Straten A, Chidanyika A, Chipato T, Jaffar S, Padian N. The importance of male partner involvement for women’s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2010(15):959–69. Montgomery ET, van der Straten A, Chidanyika A, Chipato T, Jaffar S, Padian N. The importance of male partner involvement for women’s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2010(15):959–69.
31.
go back to reference Lanham M, Wilcher R, Montgomery ET, et al. Engaging male partners in women’s microbicide use: evidence from clinical trials and implications for future research and microbicide introduction. J Int AIDS Soc. 2014;17(3 Suppl 2):19159.PubMedPubMedCentral Lanham M, Wilcher R, Montgomery ET, et al. Engaging male partners in women’s microbicide use: evidence from clinical trials and implications for future research and microbicide introduction. J Int AIDS Soc. 2014;17(3 Suppl 2):19159.PubMedPubMedCentral
32.
go back to reference MacQueen KM, Dlamini S, Perry B, et al. Social context of adherence in an open-label 1% Tenofovir Gel Trial: gender dynamics and disclosure in KwaZulu-Natal, South Africa. AIDS Behav. 2016;20(11):2682–91.CrossRefPubMedPubMedCentral MacQueen KM, Dlamini S, Perry B, et al. Social context of adherence in an open-label 1% Tenofovir Gel Trial: gender dynamics and disclosure in KwaZulu-Natal, South Africa. AIDS Behav. 2016;20(11):2682–91.CrossRefPubMedPubMedCentral
33.
go back to reference Connell RW, Messerschmidt JW. Hegemonic masculinity rethinking the concept. Gender Soc. 2005;19(6):829–59.CrossRef Connell RW, Messerschmidt JW. Hegemonic masculinity rethinking the concept. Gender Soc. 2005;19(6):829–59.CrossRef
34.
go back to reference Hunter M. The changing political economy of sex in South Africa: the significance of unemployment and inequalities to the scale of the AIDS pandemic. Soc Sci Med. 2007;64:689–700.CrossRefPubMed Hunter M. The changing political economy of sex in South Africa: the significance of unemployment and inequalities to the scale of the AIDS pandemic. Soc Sci Med. 2007;64:689–700.CrossRefPubMed
35.
go back to reference Hunter M. Love in the time of AIDS: inequality, gender, and rights in South Africa. Bloomington: Indiana University Press; 2010. Hunter M. Love in the time of AIDS: inequality, gender, and rights in South Africa. Bloomington: Indiana University Press; 2010.
36.
go back to reference van der Straten A, Panther L, Laborde N, et al. Adherence and acceptability of a multidrug vaginal ring for HIV prevention in a phase I study in the United States. AIDS Behav. 2016;20:2644–53.CrossRefPubMedPubMedCentral van der Straten A, Panther L, Laborde N, et al. Adherence and acceptability of a multidrug vaginal ring for HIV prevention in a phase I study in the United States. AIDS Behav. 2016;20:2644–53.CrossRefPubMedPubMedCentral
37.
go back to reference Creinin MD, Meyn LA, Borgatta L, et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstetr Gynecol. 2008;111:267–77.CrossRef Creinin MD, Meyn LA, Borgatta L, et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstetr Gynecol. 2008;111:267–77.CrossRef
39.
go back to reference van der Straten A, Stadler J, Montgomery E, et al. Women’s experiences with oral and vaginal pre-exposure prophylaxis: The VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.CrossRefPubMedPubMedCentral van der Straten A, Stadler J, Montgomery E, et al. Women’s experiences with oral and vaginal pre-exposure prophylaxis: The VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.CrossRefPubMedPubMedCentral
Metadata
Title
Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex
Authors
Nicole D. Laborde
Elizabeth Pleasants
Krishnaveni Reddy
Millicent Atujuna
Teopista Nakyanzi
Miria Chitukuta
Sarita Naidoo
Thesla Palanee-Phillips
Jared M. Baeten
Elizabeth T. Montgomery
On behalf of the MTN-020/ASPIRE Study Team
Publication date
01-02-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1977-1

Other articles of this Issue 2/2018

AIDS and Behavior 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine